Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Transient receptor potential (TRP) channel family consists of a diverse group of non-selective cation channels, including the well-characterized TRPV1, TRPA1, and TRPM8, which serve as cellular sensors for various physical and chemical stimuli [1, 2]. TRPV1, specifically known as the vanilloid receptor 1, is a polymodal nociceptor activated by heat, protons, and vanilloid compounds like capsaicin, playing a central role in pain signaling and thermal sensation [3, 4]. These channels are involved in numerous physiological processes, including sensory transduction, ion homeostasis, and vasomotor control, and their dysregulation is linked to chronic pain, inflammation, and respiratory disorders [5, 6]. Furthermore, the structural diversity within the TRP family allows for specialized roles in sensing mechanical stress, osmotic pressure, and various dietary chemicals [2, 6]. Pharmacological modulation of TRP channels, particularly TRPV1, involves agonists that induce desensitization or antagonists that block activation, though clinical use of systemic antagonists has been limited by side effects like hyperthermia [7, 8]. Current research focuses on developing more selective modulators and topical applications to minimize systemic toxicity while maintaining analgesic efficacy [9, 10].
Drugs targeting TRP channels, particularly TRPV1, function either as agonists or antagonists. Agonists like capsaicin cause an initial intense activation of the channel followed by a prolonged period of desensitization, effectively "defunctionalizing" the nociceptor and providing analgesia [5, 6]. Conversely, antagonists are designed to bind to the channel and prevent its opening in response to noxious stimuli such as heat or acid, thereby blocking the generation of pain signals at the source [7, 8].
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential (TRP) channel family (TRP channels).